Related Experiment Video
Updated: Apr 17, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.8K
Rhabdomyosarcoma and other pediatric temporal bone malignancies
1Bloom Otopathology Laboratory, Section of Otolaryngology-Head & Neck Surgery, Comprehensive Ear & Hearing Center, University of Chicago Medicine & Biological Sciences, MC 1035, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Otolaryngologic Clinics of North America
|February 5, 2015
Summary
This article details pediatric temporal bone cancers, focusing on rhabdomyosarcoma. It covers presentation, workup, management, and surgical options for these rare childhood tumors.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Otolaryngology
Background:
- Temporal bone malignancies are rare in children.
- Understanding their presentation and management is crucial for surgical intervention.
Purpose of the Study:
- To provide a surgeon's perspective on pediatric temporal bone cancers.
- To review the workup, management, and surgical approaches for these uncommon tumors.
- To update on rhabdomyosarcoma staging, risk, and prognosis.
Main Methods:
- Synopsis of clinical presentation and diagnostic workup.
- Review of current management strategies and surgical techniques.
- Analysis of rhabdomyosarcoma staging and risk stratification.
Main Results:
- Rhabdomyosarcoma is a key focus, with updated staging and prognosis.
- Other pediatric temporal bone cancers are reviewed.
- Surgical approaches are discussed.
Conclusions:
- Comprehensive surgical management is vital for pediatric temporal bone malignancies.
- Accurate staging and risk classification improve rhabdomyosarcoma outcomes.
- Multidisciplinary care optimizes treatment for affected children.
Related Concept Videos
The Retinoblastoma Gene
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
The Retinoblastoma Gene
2.9K
2.9K
Rous Sarcoma Virus (RSV) and Cancer
6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
6.2K

